Literature DB >> 29661951

Role of Invasive Functional Assessment in Surgical Revascularization of Coronary Artery Disease.

Bipul Baibhav1,2, Maheedhar Gedela3, Michael Moulton4, Gregory Pavlides1, Vincent Pompili1, Tanveer Rab5, George Dangas6, Deepak L Bhatt7, Aleem Siddique4, Yiannis S Chatzizisis8.   

Abstract

In patients with stable coronary artery disease, percutaneous coronary intervention is associated with improved outcomes if the lesion is deemed significant by invasive functional assessment using fractional flow reserve. Recent studies have shown that a revascularization strategy using instantaneous wave-free ratio is noninferior to fractional flow reserve in patients with intermediate-grade stenoses. The decision to perform coronary artery bypass grafting surgery is usually based on anatomic assessment of stenosis severity by coronary angiography. The data on the role of invasive functional assessment in guiding surgical revascularization are limited. In this review, we discuss the diagnostic and prognostic significance of invasive functional assessment in patients considered for coronary artery bypass grafting. In addition, we critically discuss ongoing and future clinical trials on the role of invasive functional assessment in surgical revascularization.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  coronary angiography; coronary artery bypass; coronary artery disease; fractional flow reserve; percutaneous coronary revascularization

Mesh:

Year:  2018        PMID: 29661951     DOI: 10.1161/CIRCULATIONAHA.117.031182

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  2 in total

1.  Commentary: Fractional flow reserve for coronary artery bypass graft surgery-Not yet ready for prime time.

Authors:  Harold L Lazar
Journal:  JTCVS Open       Date:  2020-11-25

2.  What should be the role of fractional flow reserve measurement in patients undergoing coronary artery bypass grafting?

Authors:  David Glineur; Aun Yeong Chong; Juan Grau
Journal:  JTCVS Open       Date:  2020-11-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.